Highly Specific Flavivirus NS1 Antibodies
The Native Antigen Company has produced an extensive range of mammalian-expressed NS1 proteins, used to raise highly specific and characterised anti-NS1 antibodies for a variety of research and development applications.
Assay Development Services
The Native Antigen Company’s assay development team has many years of experience in developing high quality assays for infectious disease and other research applications. With our wealth of experience, we offer end-to-end bespoke development with communication at every step to ensure our clients get the high quality assays they need.
Reagents for Ebola Diagnostics
To support the development of novel diagnostics, The Native Antigen Company provides a range of highly purified viral antigens, developed using our proprietary mammalian expression system. Our range includes envelope glycoproteins from both the Zaire and Bundibugyo strains, alongside Ebola VLPs, which contain nucleoprotein, glycoprotein and VP40 antigens.
About The Native Antigen Company
The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. The company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company’s high-quality reagents are widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.